Showing results (91-100 of 496) with videos related to
Sort By:
Pageof 50
European Journal of Cancer (Oxford, England : 1990)|October 23, 2018
Mapping cancer research across Central and Eastern Europe, the Russian Federation and Central Asia: Implications for future national cancer control planningMursheda Begum, Grant Lewison, Jacek Jassem, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 24, 2026
Value, Access, and High-Quality Medical Oncology Care: Can We Have It All?Ian F Tannock, Ajay Aggarwal, Haydee Verduzco-Aguirre, et al.International Braz J Urol : Official Journal of the Brazilian Society of Urology|October 19, 2019
Assessment of long term outcomes after buccal mucosal graft urethroplasty: the impact of chronic kidney diseaseManoj Kumar, Ajay Aggarwal, Siddharth Pandey, et al.The Journal of Knee Surgery|December 23, 2017
Day of Week and Surgery Location Effects on Stay Length and Cost for Total Joint Arthroplasty: Academic versus Orthopaedic-Specific HospitalJohn Martino, Blake Peterson, Samuel Thompson, et al.Molecular Cancer Therapeutics|June 11, 2009
Hypoxia prevents etoposide-induced DNA damage in cancer cells through a mechanism involving hypoxia-inducible factor 1Richard Sullivan, Charles H GrahamCancer Metastasis Reviews|April 27, 2007
Hypoxia-driven selection of the metastatic phenotypeRichard Sullivan, Charles H GrahamCurrent Pharmaceutical Design|May 14, 2008
Chemosensitization of cancer by nitric oxideRichard Sullivan, Charles H GrahamJapanese Journal of Clinical Oncology|October 29, 2013
Cancer control in BangladeshSyed Akram Hussain, Richard SullivanCancer|June 29, 2023
Allocation of authorship and patient enrollment among global clinical trials in oncologyFidel Rubagumya, Adam Fundytus, Sophie Keith-Brown, et al.BMJ (Clinical Research Ed.)|October 6, 2017
Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009-13Courtney Davis, Huseyin Naci, Evrim Gurpinar, et al.Pageof 50